<?xml version="1.0" encoding="UTF-8"?>
<p>Maoto has been shown to be effective for reducing fever in children infected with influenza viruses [
 <xref rid="B5" ref-type="bibr">5</xref>, 
 <xref rid="B6" ref-type="bibr">6</xref>]. Infection experiments with an influenza virus in cultured cells have also shown that maoto inhibits virus growth 
 <italic>in vitro</italic> [
 <xref rid="B7" ref-type="bibr">7</xref>]. It has also been reported that maoto inhibited influenza virus replication in the lungs of mice and exhibited antipyretic effects [
 <xref rid="B13" ref-type="bibr">13</xref>]. Although no direct inhibition of the growth of influenza viruses by kakkonto has been reported, toll-like receptor 4-dependent adjuvant activity of kakkonto [
 <xref rid="B16" ref-type="bibr">16</xref>] and the possibility of kakkonto inhibiting the onset of influenza encephalopathy by acting on the blood-brain barrier [
 <xref rid="B17" ref-type="bibr">17</xref>] have been reported. Jiinkokato and senkyuchachosan have not been reported to be associated with influenza viruses, and this is the first report about the effects of those Kampo drugs on influenza virus.
</p>
